Enzo Biochem (ENZ) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Royalty and license fee income: 300K
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Royalty and license fee income: 300K
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $32.6 million, versus $0 reported last year.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
